돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 323193생성일: 2026년 10월 26일

Ethyl 4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-YL]amino]piperidine-1-carboxylate → Tecastemizole

https://huagongshe.com/reaction/323193

반응식

참여 물질

역할이름HCID투입량
반응물Ethyl 4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-YL]amino]piperidine-1-carboxylateHCID 3019916—
용매Hydrogen BromideHCID 260—
생성물TecastemizoleHCID 123618—

반응 단계

Combine (1-(4-fluorobenzyl)-1H-benzimidazol-2-yl)-(1-ethoxycarbonyl-piperidin-4-yl)amine (31.5 g, 79.4 mmol) and 48% hydrobromic acid (250 mL). Heat to reflux. After 1.5 hours, cool and evaporate in vacuo to give a residue. Add water and sodium hydroxide (60 g) and extract with chloroform. Dry the organic layer over Na2SO4, filter, and concentrate in vacuo to obtain a solid. Collect the solid by filtration and recrystallize from hexane/chloroform to give, after drying, the title compound: mp; 212-215° C.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06211199B1
출처 데이터셋uspto-grants-2001_04
ORD IDord-80d71fb58aea40af941dbd037c6b7708
출처 메모uspto-grants-2001_04